Global Covid-19 funding round-up
Posted on 01/05/2020
This is a round-up of some of the funding opportunities available for the global fight against Covid-19. If you would like to add a funding opportunity, please contact us.
There are also further opportunities at our global initiatives and resources page.
Five new Horizon 2020 coronavirus-related funding calls
Repurposing of manufacturing for vital medical supplies and equipment (SC1-PHE-CORONAVIRUS-2020-2A)
This focus area addresses any manufacturer able to deliver demonstrators of a flexible 48-hour industrial response capability at scale, to cope with sudden spikes in demand of strategic products (for instance medical equipment such as PPE, respirators), for requalification or release of production lines. Open Innovation Testbeds, laboratories, other technology infrastructures and maker communities may in particular be relevant.
Recommended grant amount: €5m-€6m, but applications for other amounts are welcome.
Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL) (SC1-PHE-CORONAVIRUS-2020-2B)
This topic has two strands:
Support solutions that are close-to-market (TRL 7) in one of the COVID-19 areas mentioned and that have already received, or are about to receive, the CE marking to proceed to large scale testing, piloting and deployment operations in critical healthcare areas (or wherever else is relevant) (type 1);
Support market innovation (from lab-to-fab) for further developing and maturing innovative solutions that have already been validated in lab environments (TRL 6-7 or higher) with the aim to help accelerate developments and achieve conformity assessment (CE marking) (type 2).
Recommended grant: €2m-€5m (or up to €10m with financial support from third parties)
Behavioural, social and economic impacts of the outbreak response (SC1-PHE-CORONAVIRUS-2020-2C)
Proposals should focus on lessons learnt: they should i) address how to mitigate social and economic impacts of the outbreak response related to health systems; ii) identify non-intended consequences of epidemic-control decisions; and iii) provide answers to social, including gendered, dynamics of the outbreak and the related public health response. Proposals should analyse the effects and efficiency of these responses (including resilience factors), democratic governance, multi-level cooperation, the critical gaps and the various exit strategies, their underlying methodologies and regional adaptations. Proposals are expected to develop guidelines and best ‘next practices’, and implement interventions to mitigate impacts and boost wellbeing.
Recommended grant: €4m-€10m
Pan-European COVID-19 cohorts (SC1-PHE-CORONAVIRUS-2020-2D)
Proposals submitted under this expression of interest are expected to establish new and/or build on existing large-scale cohorts to rapidly advance the knowledge on the control of the SARS-CoV-2 infection, develop evidence-based recommendations for effective prevention of the spreading, protection of the population in the coming months/years, and optimized treatment of the COVID-19 patients. The population-based cohorts should also inform on longer-term consequences of COVID-19 on health and well-being of individuals.
Recommended grant: €15m-€20m
Networking of existing EU and international cohorts of relevance to COVID-19 (SC1-PHE-CORONAVIRUS-2020-2E)
Proposals under this coordination and support action should support the international networking of existing, mainly longitudinal, cohorts in order to extract jointly agreed standardized data on COVID-19 diagnosed/serotyped and matched non-infected individuals. This effort should contribute to help in the identification of key factors influencing the susceptibility to infection and clinical manifestation, to assess the optimized therapeutic and clinical management options, and to derive lessons on the health and socio-economic impacts of the pandemic. They should develop cohort readiness to adapt rapidly to future crisis. Proposals should consider strategies to interact with the COVID-19 cohort(s) that will be funded under this expression of interest and international initiatives on cohorts, as well as liaising with the network of clinical trials on COVID-19.
Recommended grant: €2m-€3m
European Institute of Innovation & Technology: Crisis Response Initiative
As part of the EU’s collective efforts to tackle the COVID-19 crisis, the EIT has launched the ‘EIT Crisis Response Initiative’. The EIT Governing Board has decided to mobilise EUR 60 million of additional funding to innovators powering high-impact solutions that tackle this unprecedented social and economic challenge. The financing will allow the launch of new innovation projects to address the immediate crisis as part of the ‘Pandemic Response Projects’, and will support highly innovative start-ups, scale-ups and SMEs crucial to the economy’s fast recovery to benefit from additional funding under the ‘Venture Support Instrument’.
The new EIT initiative consists of two main tracks of activities to be implemented by the EIT’s Knowledge and Innovation Communities across Europe:
- Venture Support Instrument: Start-ups, scale-ups and SMEs have been enormously impacted by the COVID-19 crisis, with investment drying up and significant cash flow issues emerging. Additional EIT support (financing, technical assistance and network) will help highly innovative ventures weather the crisis and accelerate their growth.
- Pandemic Response Projects: More than ever, innovations and new solutions are needed to tackle the current crisis and prevent its resurgence. The EIT ecosystem is agile and will mobilise innovators to address the COVID-19 crisis impact, both in terms of the immediate health concerns and the wider response needed.
The EUR 60 million financing will power innovations in health, climate change, digitisation, food, sustainable energy, urban mobility, manufacturing and raw materials.
Some of the calls have short deadlines and have already closed. Current open calls include:
EIT Food: COVID-19 Rapid Response Call for Innovation projects – closes 28th May
EIT Food COVID-19 Bridge Fund – closes 28th May
EIT Urban Mobility – closes 31st May
EIT Health Start-up Rescue Instrument (apply to receive up to EUR 500 000 in co-investment from EIT Health, in return for options) – closes 1st June
Accelerating support to innovators during the COVID-19 crisis (activities along the whole raw materials value chain) – closes 12th June
For more information, click here.
COVID-19 Africa Rapid Grant Fund
SGCI participating councils across 15 countries in sub-Saharan Africa are pleased to announce the COVID-19 Africa Rapid Grant Fund. The Rapid Grant Fund seeks to contribute to the African regional and continental response to the COVID-19 pandemic.
This call covers three strands: i) research, ii) science engagement: call to science and health journalists and communicators, and iii) science engagement: call to science advisers.
Researchers and science engagement practitioners from the following countries are eligible to apply: Botswana, Burkina Faso, Côte d’Ivoire, Ethiopia, Ghana, Kenya, Malawi, Mozambique, Namibia, Rwanda, Senegal, Tanzania, Uganda, Zambia, Zimbabwe, and in the context of the African Research Universities Alliance (ARUA) Nigeria and South Africa. For the research strand and applicable only to Nigeria and South Africa, only ARUA member universities will be eligible to participate. For this strand, the lead PI must be in possession of a PhD with a minimum of five years of active fulltime research experience at the time of application.
For the two strands on science engagement, practitioners across all the countries, including Nigeria and South Africa may apply.
Applications from women applicants, people living with disabilities and first responders to COVID-19, as principal investigators are encouraged.
For research projects, the maximum grant is $100,000 (US dollars) with a maximum project duration of 24 months.
For science engagement (journalists and communicators), the maximum grant is $20,000 with a maximum duration of 18 months.
For science engagement (science advisers) the maximum grant is $50,000 with a maximum duration of 24 months.
The closing date is Wednesday, 17 June 2020, 24:00 Central Africa Time (CAT).
DFID’s Frontier Tech Hub #COVIDaction call
The Department for International Development‘s (DFID’s) Frontier Tech Hub #COVIDaction team, in partnership with the Royal Academy of Engineering, is seeking innovative approaches to shorten supply chains, pivot manufacturing, source raw materials and create new products to address demand in Low- and Middle-Income Countries. It has launched a call for Local Solutions: the call is seeking innovative, locally designed and produced solutions needed for COVID-19 response: PPE, components of PPE, parts to support production of PPE, and/or other solutions in response to local needs.
Applicants could receive up to £50,000 in grant funding, access to technical experts and match-making to DFID programmes, potential to be published in a virtual showcase and more.
The aim of #COVIDaction is to build a technology and innovation pipeline to support COVID-19 response. The team set out to scan for tech innovation in DFID countries (and globally), cut through the noise, make sense of ‘what’s working’ to then share what has been learned and uncovered as a global, public good.
Travel and subsistence to support low and middle-income country engagement
The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to Covid-19 in low and middle-income countries. The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation.
Applications are open until further notice, on a rolling basis. Applications should ideally be submitted at least 2 weeks before planned travel.
Click here for more details.
Further worldwide funding opportunities
MIT Health Security & Pandemics Challenge – How can communities around the world prepare for, detect, and respond to emerging pandemics and health security threats? Prizes of up to $1m available. Closes 18 June 2020.
AWS Diagnostic Development Initiative – support for innovation in rapid and accurate patient testing for 2019 novel coronavirus (COVID-19), and other diagnostic solutions to mitigate future outbreaks. Reward – technical support and providing AWS promotional credits to support the use of AWS services to advance diagnostic research for selected institutions and companies. Initial submission period ends 30 June 2020.
Call for Code Global Challenge – mitigate the impact of Covid-19 and climate change by creating sustainable solutions using open source technology. $200k top prize, enter by 31 July 2020.
Competitive Fund for Peace and Recovery – Innovation for Poverty Action’s Peace & Recovery Program is accepting off-cycle proposals, capped at $50,000, for time-sensitive additions to research projects that study or support the Covid-19 response. Applications reviewed on a rolling basis.
Science|Business database of funding opportunities
The Silicon Valley Bank COVID-19 Global Impact & Innovation Fund – Its mission is to mobilize the innovation community to fund direct relief and long-term resilience in the face of COVID-19.
Fast Funding for Covid-19 Science – A new venture fund is offering grants of $10,000 to $500,000 to coronavirus researchers, and every grant decision will be made in less than 48 hours. The fund, Fast Grants, has raised $10 million from 10 backers including Paul Graham, Stripe cofounders John and Patrick Collison, and LinkedIn cofounder Reid Hoffman. As of 16 April, applications are paused but may reopen in the future: check the site for updates and to sign up for notification of reopening. For more information, click here.